nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.11.2016 | Review

Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma

verfasst von: A. D. Fisher, J. Ristori, E. Fanni, G. Castellini, G. Forti, M. Maggi

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 11/2016

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Disorders of Sex Development (DSD) are a wide range of congenital conditions characterized by an incongruence of components involved in sexual differentiation, including gender psychosexual development. The management of such disorders is complex, and one of the most crucial decision is represented by gender assignment. In fact, the primary goal in DSD is to have a gender assignment consistent with the underlying gender identity in order to prevent the distress related to a forthcoming Gender Dysphoria. Historically, gender assignment was based essentially on surgical outcomes, assuming the neutrality of gender identity at birth. This policy has been challenged in the past decade refocusing on the importance of prenatal and postnatal hormonal and genetic influences on psychosexual development.

Aims

(1) to update the main psychological and medical issues that surround DSD, in particular regarding gender identity and gender assignment; (2) to report specific clinical recommendations according to the different diagnosis.

Methods

A systematic search of published evidence was performed using Medline (from 1972 to March 2016). Review of the relevant literature and recommendations was based on authors’ expertise.

Results

A review of gender identity and assignment in DSD is provided as well as clinical recommendations for the management of individuals with DSD.

Conclusions

Given the complexity of this management, DSD individuals and their families need to be supported by a specialized multidisciplinary team, which has been universally recognized as the best practice for intersexual conditions. In case of juvenile GD in DSD, the prescription of gonadotropin-releasing hormone analogues, following the World Professional Association for Transgender Health and the Endocrine Society guidelines, should be considered. It should always be taken into account that every DSD person is unique and has to be treated with individualized care. In this perspective, international registries are crucial to improve the understanding of these challenging conditions and clinical practice, in providing a better prediction of gender identity.

Kim SS, Kolon TF (2009) Hormonal abnormalities leading to disorders of sexual development. Expert Rev Endocrinol Metab 4:161–172CrossRef

Hiort O, Birinbaun W, Marshall L, Wunsch L, Werner R, Schroder T, Dohnert U, Hoterhus PM (2014) Management of disorders of sex development. Nat Rev Endocrinol 10:520–529PubMedCrossRef

Jost A (1972) A new look at the mechanism controlling sex differentiation in mammals. Johns Hopkins Med J 130:38–53PubMed

Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R (1991) Male development of chromosomally female mice transgenic for SRY. Nature 351:117–121PubMedCrossRef

Achermann JC, Hughes IA (2008) Disorders of sex development. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology, 11th edn. Elsevier Saunders, Philadelphia

Cameron F, Smith C (2004) Embryology of the female genital tract. In: Balen A, Creighton S, Davies MC, MacDougall J, Stanhope R (eds) Paediatric and adolescent gynaecology: a multidisciplinary approach. Cambridge University Press, Cambridge, pp 3–8CrossRef

Migeon CJ, Wisniewski AB (2003) Human sex differentiation and its abnormalities. Best Pract Res Clin Obstet Gynaecol 17:1–18PubMedCrossRef

Siiteri PK, Wilson JD (1974) Testosterone formation and metabolism during male sexual differentiation in the human embryo. J Clin Endocrinol Metab 38:113–125PubMedCrossRef

Sinclair AH, Berta P, Palmer MS, Hawkins JR, Griffiths BL, Smith MJ, Foster JW, Frischauf AM, Lovell-Badge R, Goodfellow PN (1990) A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif. Nature 346:240–244PubMedCrossRef

10.

Pasterski V (2008) Disorders of sex development and atypical sex differentiation. In: Rowland DL, Incrocci L (eds) Handbook of sexual and gender identity disorders. Wiley, Hoboken, pp 354–374

11.

Money J, Hampson JG, Hampson JL (1955) An examination of some basic sexual concepts: the evidence of human hermaphroditism. Bull Johns Hopkins Hosp 97:301–319PubMed

12.

Gooren L (2010) The endocrinology of sexual behavior and gender identity. In: Jameson L, de Groot LJ (eds) Endocrinology—adult and pediatric, 6th edn. Elsevier Saunders, Philadelphia

13.

Arnold AP (2009) The organizational–activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav 55:570–578PubMedPubMedCentralCrossRef

14.

Bramen JE, Hranilovich JA, Dahl RE, Chen J, Rosso C, Forbes EE, Dinov ID, Worthman CM, Sowell ER (2012) Sex matters during adolescence: testosterone-related cortical thickness maturation differs between boys and girls. PLoS ONE 7:e33850PubMedPubMedCentralCrossRef

15.

Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, Paus T, Evans AC, Rapoport JL (1999) Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2:861–863PubMedCrossRef

16.

Lenroot RK, Gogtay N, Greenstein DK, Molloy Wells E, Wallace GL, Clasen LS, Blumenthal JD, Lerch J, Zejdenbos AP, Evans AC, Thomphons PM, Giedd JN (2007) Sexual dimorphism of brain developmental trajectories during childhood and adolescence. Neuroimage 36:1065–1073PubMedPubMedCentralCrossRef

17.

McCarthy MM, Arnold AP (2011) Reframing sexual differentiation of the brain. Nat Neurosci 14:677–683PubMedPubMedCentralCrossRef

18.

Phoenix CH, Goy RW, Gerall AA, Young WC (1959) Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology 65:369–382PubMedCrossRef

19.

Meyer-Bahlburg HFL, Baratz Dalke K, Berenbaum SA, Cohen-Kettenis PT, Hines M, Schober JM (2016) Gender assignment, reassignment and outcome in disorders of sex development: update of the 2005 consensus conference. Horm Res Paediatr 85:112–118PubMedCrossRef

20.

Quigley CA (2002) Editorial: the postnatal gonadotropin and sex steroid surge-insights from the androgen insensitivity syndrome. J Clin Endocrinol Metab 87:8–24

21.

Swaab DF (2007) Sexual differentiation of the brain and behavior. Best Pract Res Clin Endocrinol Metab 21:431–444PubMedCrossRef

22.

Swaab DF (2004) The human hypothalamus. Basic and clinical aspects. Part II: neuropathology of the hypothalamus and adjacent brain structures. In: Aminoff MJ, Boller F, Swaab DF (eds) Handbook of clinical neurology. Elsevier, Amsterdam

23.

Cohen-Brendahan CC, Van de Beek C, Berendbaum SA (2005) Prenatal sex hormone effects on child and adult sex-typed behavior: methods and findings. Neurosci Biobehav Rev 29:353–384CrossRef

24.

Jürgensen M, Kleinemeier E, Lux A, Steensma TD, Cohen-Kettenis PT, Hiort O, Thyen U, Köhler B, DSD Network Working Group (2012) Psychosexual development in adolescents and adults with disorders of sex development: results from the German Clinical Evaluation Study. J Sex Med 10:2703–2714PubMedCrossRef

25.

Meyer-Bahlburg HF (2013) Sex steroids and variants of gender identity. Endocrinol Metab Clin North Am 42:435–452PubMedCrossRef

26.

Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI (2004) Prenatal androgenization affects gender-related behavior but not gender identity in 5–12 years old girls with congenital adrenal hyperplasia. Arch Sex Behav 33:97–104PubMedCrossRef

27.

Money J (1994) The concept of gender identity disorder in childhood and adolescence after 39 years. J Sex Marital Ther 20:163–177PubMedCrossRef

28.

Zucker KJ (2002) Intersexuality and gender identity differentiation. J Pediatr Adolesc Gynecol 15:3–13PubMedCrossRef

29.

Byne W (2006) Developmental endocrine influences on gender identity: implications for management of disorders of sex development. Mt Sinai J Med 73:950–959PubMed

30.

Gooren L (1990) The endocrinology of transsexualism: a review and commentary. Psychoneuroendocrinology 5:3–14CrossRef

31.

Gooren L (2006) The biology of human psychosexual differentiation. Horm Behav 50:589–601PubMedCrossRef

32.

Money J (1981) The development of sexuality and eroticism in humankind. Q Rev Biol 56:379–404PubMedCrossRef

33.

Meyer-Bahlburg HF (2010) From mental disorder to iatrogenic hypogonadism: dilemmas in conceptualizing gender identity variants as psychiatric conditions. Arch Sex Behav 39:461–476PubMedPubMedCentralCrossRef

34.

Hughes IA (2008) Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metabol 22:119–134CrossRef

35.

Houk CP, Lee PA (2010) Approach to assigning gender in 46, xx congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab 95:4501–4508PubMedCrossRef

36.

Bao AM, Swaab DF (2011) Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders. Front Neuroendocrinol 32:214–226PubMedCrossRef

37.

American Psychiatric Association (2013) DSM-5: diagnostic and statistical manual for mental disorders, 5th edn. American Psychiatric Press, Washington, DCCrossRef

38.

Kruijver FP, Zhou JN, Pool CW, Hofman MA, Gooren LJ, Swaab DF (2000) Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab 85:2034–2041PubMedCrossRef

39.

Zhou JN, Hofman MA, Gooren LJ, Swaab DF (1995) A sex difference in the human brain and its relation to transsexuality. Nature 378:68–70PubMedCrossRef

40.

Smith ES, Junger J, Derntl B, Habel U (2015) The transsexual brain—a review of findings on the neural basis of transsexualism. Neurosci Biobehav Rev 59:251–266PubMedCrossRef

41.

Luders E, Sánchez FJ, Gaser C, Toga AW, Narr KL, Hamilton LS, Vilain E (2009) Regional gray matter variation in male-to-female transsexualism. Neuroimage 46:904–907PubMedPubMedCentralCrossRef

42.

Garcia-Falgueras A, Swaab DF (2008) A sex difference in the hypothalamic uncinate nucleus: relationship to gender identity. Brain 131:3132–3146PubMedCrossRef

43.

Berglund H, Lindstrom P, Dhejne-Helmy C, Savic I (2008) Male to female transsexuals show sex-atypical hypothalamus activation when smelling odorous steroids. Cerebr Cortex 18:1900–1908CrossRef

44.

Gizewski ER, Krause E, Schlamann M, Happich F, Ladd ME, Forsting M, Senf W (2009) Specific cerebral activation due to visual erotic stimuli in male-to-female transsexuals compared with male and female controls: an fMRI study. J Sex Med 6:440–448PubMedCrossRef

45.

Burke SM, Menks WM, Cohen-Kettenis PT, Klink DT, Bakker J (2014) Click-evoked otoacoustic emissions in children and adolescents with gender identity disorder. Arch Sex Behav 43:1515–1523PubMedCrossRef

46.

Ciocca G, Limoncin E, Cellerino A, Fisher AD, Gravina GL, Carosa E, Mollaioli D, Valenzano DR, Mennucci A, Bandini E, Di Stasi SM, Maggi M, Lenzi A, Jannini EA (2014) Gender identity rather than sexual orientation impacts on facial preferences. J Sex Med 11:2500–2507PubMedCrossRef

47.

Hare L, Bernard P, Sànchez FJ, Baird PN, Vilain E, Kennedy T, Harley VR (2009) Androgen receptor repeat length polymorphism associated with male-to-female transsexualism. Biol Psychiatry 65:93–96PubMedCrossRef

48.

Bentz EK, Hefler LA, Kaufmann U, Huber JC, Kolbus A, Tempfer CB (2008) A polymorphism of the CYP17 gene related to sex steroid metabolism is associated with female to male but not male to female transsexualism. Fertil Steril 90:56–59PubMedCrossRef

49.

Henningsson S, Westberg L, Nilsson S, Lundström B, Ekselius L, Bodlund O, Lindström E, Hellstrand M, Rosmond R, Eriksson E, Landén M (2005) Sex steroid-related genes and male-to-female transsexualism. Psychoneuroendocrinology 30:657–664PubMedCrossRef

50.

Fisher AD (2013) Disorders of sex development. In: Kirana PS, Tripodi F, Reisman Y, Porst H (eds) The EFS and ESSM syllabus of clinical sexology. Medix publishers, Amsterdam

51.

Fisher AD, Ristori J, Bandini E, Giordano S, Mosconi M, Jannini EA, Greggio NA, Godano A, Manieri C, Meriggiola C, Ricca V, Italian GnRH analogs study ONIG group, Dettore D, Maggi M (2014) Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG. J Endocrinol Invest 37:675–687PubMedCrossRef

52.

Fisk NM (1974) Editorial: gender dysphoria syndrome—the conceptualization that liberalizes indications for total gender reorientation and implies a broadly based multi-dimensional rehabilitative regimen. West J Med 120:386–391PubMedPubMedCentral

53.

Meyer-Bahlburg HF (2005) Introduction: gender dysphoria and gender change in persons with intersexuality. Arch Sex Behav 34:371–373PubMedCrossRef

54.

Mayfield W (2001) The development of an internalized homonegativity inventory for gay men. J Homosex 41:53–76PubMedCrossRef

55.

Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES Consensus Group; ESPE Consensus Group (2006) Consensus statement on management of intersex disorders. Arch Dis Child 91:554–563PubMedPubMedCentralCrossRef

56.

Bashamboo A, McElreavey K (2015) Human sex-determination and disorders of sex-development (DSD). Semin Cell Dev Biol 45:77–83PubMedCrossRef

57.

McCann-Crosby B, Sutton VR (2015) Disorders of sexual development. Clin Perinatol 42(2):395–412 (ix–x) PubMedCrossRef

58.

El-Khairi R, Achermann JC (2012) Steroidogenic factor-1 and human disease. Semin Reprod Med 30:374–381PubMedCrossRef

59.

Jääskeläinen M, Prunskaite-Hyyryläinen R, Naillat F, Parviainen H, Anttonen M, Heikinheimo M, Liakka A, Ola R, Vainio S, Vaskivuo TE, Tapanainen JS (2010) WNT4 is expressed in human fetal and adult ovaries and its signaling contributes to ovarian cell survival. Mol Cell Endocrinol 317:106–111PubMedCrossRef

60.

Tomaselli S, Megiorni F, Lin L, Mazzilli MC, Gerrelli D, Majore S, Grammatico P, Achermann JC (2011) Human RSPO1/R-spondin1 is expressed during early ovary development and augments β-catenin signaling. PLoS ONE 6:e16366PubMedPubMedCentralCrossRef

61.

Yang JH, Baskin LS, Disandro M (2010) Gender identity in disorders of sex development: review article. Urology 75:153–159PubMedCrossRef

62.

DiSandro M, Merke DP, Rink RC (2015) Review of current surgical techniques and medical management considerations in the treatment of pediatric patients with disorders of sex development. Horm Metab Res 47:321–328PubMedCrossRef

63.

Ercan O, Kutlug S, Uysal O, Alikasifoglu M, Inceoglu D (2013) Gender identity and gender role in DSD patients raised as females: a preliminary outcome study. Front Endocrinol (Lausanne) 4:86

64.

Money J (1975) Ablatio penis: normal male infant sex-reassigned as a girl. Arch Sex Behav 4:65–71PubMedCrossRef

65.

Chase C (1998) Surgical progress is not the answer to intersexuality. J Clinical Ethics 9:385–392

66.

Bouvattler C, Mignot B, Lefevre H, Morel Y, Bougneres P (2006) Impaired sexual activity in male adults with partial androgen insensitivity. J Clin Endocrinol Metab 91:3310–3315CrossRef

67.

Hooper HT, Figuiredo BC, Pavan-Senn CC, de Lacerca L, Sandrini R, Mengarelli JK, Japp K, Karaviti LP (2004) Concordance of phenotypic expression and gender identity in a large kindred with a mutation in the androgen receptor. Clin Genet 65:183–190PubMedCrossRef

68.

Jürgensen M, Kleinemeier E, Lux A, Steemsa TD, Cohen-Kettenis PT, Hiort O, Thyen U, DSD Network Working Group (2010) Psychosexual development in children with disorder of sex development—results from the German Clinical Evaluation Study. J Pediatr Endocrinol Metab 23:565–578PubMedCrossRef

69.

Jürgensen M, Lux A, Wien SB, Kleinemeier E, Hiort O, Thyen U (2014) Health-related quality of life in children with disorders of sex development (DSD). Eur J Pediatr 173:893–903PubMedCrossRef

70.

Mazur T, Sandberg DE, Perrin MA, Gallagher JA, MacGillivray MH (2004) Male pseudohermaphroditism: long-term quality of life outcome in five 46, XY individuals reared female. J Pediatr Endocrinol Metab 17:809–823PubMedCrossRef

71.

Migeon CJ, Wisniewski AB, Gearhart JP, Meyer-Bahlburg HF, Rock JA, Brown TR, Casella SJ, Maret A, Ngai KM, Money J, Berkovitz GD (2002) Ambiguous genitalia with perineo-scrotal hypospadias in 46, XY individuals: long-term medical, surgical and psychosexual outcome. Pediatrics 110:e31PubMedCrossRef

72.

Houk CP, Hughes IA, Ahmed SF, Lee PA (2006) Summary of consensus statement on intersex disorders and their management. International Intersex Consensus Conference. Pediatrics 118:753–757PubMed

73.

van der Zwan YG, Callens N, van Kuppenveld J, Kwak K, Drop SL, Kortmann B, Dessens AB, Wolffenbuttel KP, Dutch Study Group on DSD (2013) Long-term outcomes in males with disorders of sex development. J Urol 190:1038–1042PubMedCrossRef

74.

Warne G, Grover S, Hutson J, Sinclair A, Metcalfe S, Northam F, Freeman J, Murdoch Childrens Research Institute Sex Study Group (2005) A long-term outcome study of intersex conditions. J Pediatr Endocrinol Metab 18:555–567PubMedCrossRef

75.

Lee PA, Nordenström A, Houk CP, Ahmed SF, Auchus R, Baratz A, Baratz Dalke K, Liao LM, Lin-Su K, Looijenga LH 3rd, Mazur T, Meyer-Bahlburg HF, Mouriquand P, Quigley CA, Sandberg DE, Vilain E, Witchel S, Global DSD update consortium (2016) Global disorders of sex development update since 2006: perceptions, approach and care. Horm Res Paediatr 85:158–180PubMedCrossRef

76.

Cheon CK (2011) Practical approach to steroid 5alpha-reductase type 2 deficiency. Eur J Pediatr 170:1–8PubMedCrossRef

77.

Cohen-Kettenis PT (2005) Gender change in 46, XY persons with 5alfa-reductase-2 deficiency and 17alpha-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 34:399–410PubMedCrossRef

78.

Nordenström A, Frisén L, Falhammar H, Filipsson H, Holmdahl G, Janson PO, Thorén M, Hagenfeldt K, Nordenskjöld A (2010) A: sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients’ perception. J Clin Endocrinol Metab 95:3633–3640PubMedCrossRef

79.

Mendonca BB, Domenice S, Arnhold IJ, Costa EM (2009) 46, XY disorders of sex development (DSD). Clin Endocrinol 70:173–187

80.

Kim SK, Kim J (2012) Disorder of sex development. Korean J Urol 53:1–8PubMedPubMedCentralCrossRef

81.

Suresh D, Crawford J, Axelrad ME, Gunn SK, McCullough L, Smith OB, Sutton VR, Roth D, Karaviti LP, Dietrich JE (2013) Assessing sex assignment concordance with genotype and phenotype. Int J Pediatr Endocrinol 2013:7PubMedPubMedCentralCrossRef

82.

Özbaran B, Özen S, Gökşen D, Korkmaz Ö, Onay H, Özkınay F, Çoğulu Ö, Erermiş S, Köse S, Avanoğlu A, Ulman İ, Darcan Ş (2013) Psychiatric approaches for disorders of sex development: experience of a multidisciplinary team. J Clin Res Pediatr Endocrinol 5:229–235PubMedPubMedCentralCrossRef

83.

Sandberg D, Mazur T (2014) A non categorical approach to the psychosocial care of persons with DSD and their families. In: Kreukels BP, Steensma TD, de Vries AL (eds) Gender dysphoria and disorders of sex development. Focus on sexuality research. Springer, Berlin, pp 93–114CrossRef

84.

Brook CGD, Clayton P, Brown R (2009) Brook’s clinical pediatric endocrinology, 6th edn. Wiley-Blackwell, HobokenCrossRef

85.

Chowdhury TK, Chowdhury MZ, Mili F, Hutson JM, Banu T (2014) Gender identity shows a high correlation with Prader score in patients with disorders of sex development (DSD) presenting in mid childhood. Pediatr Surg Int 30:527–532PubMedCrossRef

86.

Steensma TD, Biemond R, de Boer F, Cohen-Kettenis PT (2011) Desisting and persisting gender dysphoria after childhood: a qualitative follow-up study. Clin Child Psychol Psychiatry 16:499–516PubMedCrossRef

87.

Steensma TD, McGuire JK, Kreukels BP, Beekman AJ, Cohen-Kettenis PT (2013) Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study. J Am Acad Child Adolesc Psychiatry 52:582–590PubMedCrossRef

88.

Cohen-Kettenis PT, Delemarre-van de Waal HA, Gooren LJ (2008) The treatment of adolescent transsexuals: changing insights. J Sex Med 5:1892–1897PubMedCrossRef

89.

Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, Fraser L, Green J, Knudson G, Meyer WJ, Monstrey S, Adler RK, Brown GR, Devor AH, Ehrbar R, Ettner R, Eyler E, Garofalo R, Karasic DH, Lev AI, Mayer G, Meyer-Bahlburg H, Hall BP, Pfaefflin F, Rachlin K, Robinson B, Schechter LS, Tangpricha V, van Trotsenburg M, Vitale A, Winter S, Whittle S, Wylie KR, Zucker K (2011) Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7. Int J Transgend 13:165–232CrossRef

90.

Hembree WC, Choen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ III, Spack NP, Tangpricha V, Montori VM, Endocrine Society (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132–3154PubMedCrossRef

91.

Hewitt J, Zacharin M (2015) Hormone replacement in disorders of sex development: current thinking. Best Pract Res Clin Endocrinol Metab 29:437–447PubMedCrossRef

92.

Sadjadi S (2013) The endocrinologist’s office-puberty suppression: saving children from a natural disaster? J Med Humanit 3:255–260CrossRef

93.

Park R, Consortium on the Management of Disorders of Sex Development (2006) Clinical guidelines for the management of disorders of sex development in childhood. Intersex Society of North America, Whitehouse station, NJ

94.

Bukowski WM, McCauley E, Mazur T (2015) Disorders of sex development (DSD): peer relations and psychosocial well-being. Horm Metab Res 47:357–360PubMedCrossRef

95.

McCann-Crosby B, Sutton VR (2015) Disorders of sexual development. Clin Perinatol 42:395–412 (ix–x) PubMedCrossRef

96.

Sandberg DE, Gardner M, Cohen-Kettenis PT (2012) Psychological aspects of the treatment of patients with disorders of sex development. Semin Reprod Med 30:443–452PubMedPubMedCentralCrossRef

97.

98.

Nordenström A (2015) Psychosocial factors in disorders of sex development in a long-term perspective: what clinical opportunities are there to intervene? Horm Metab Res 47:351–356PubMedCrossRef

99.

Schweizer K, Brunner F, Handford C, Richter-Appelt H (2014) Gender experience and satisfaction with gender allocation in adults with diverse intersex conditions (divergences of sex development, DSD). Psychol Sex 5:56–82

100.

Schönbucher V, Schweizer K, Richter-Appelt H (2010) Sexual quality of life of individuals with disorders of sex development and a 46, XY karyotype: a review of international research. J Sex Marital Ther 36:193–215PubMedCrossRef

101.

Chadwick PM, Liao LM, Boyle M (2005) Size matters: experiences of atypical genital and sexual development in males. J Health Psychol 10:529–543PubMedCrossRef

102.

Minto CL, Liao KLM, Conway GS, Creighton SM (2003) Sexual function in women with complete androgen insensitivity syndrome. Fertile Steril 80:157–164CrossRef

103.

Suorsa KI, Mullins AJ, Tackett AP, Reyes KJ, Austin P, Baskin L, Bernabé K, Cheng E, Fried A, Frimberger D, Galan D, Gonzalez L, Greenfield S, Kropp B, Meyer S, Meyer T, Nokoff N, Palmer B, Poppas D, Paradis A, Yerkes E, Wisniewski AB, Mullins LL (2015) Characterizing early psychosocial functioning of parents of children with moderate to severe genital ambiguity due to disorders of sex. Development 194:1737–1742

104.

Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL (1999) Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. J Pediatr 134:579–583PubMedCrossRef

105.

Chen MJ, Vu BM, Axelrad M, Dietrich JE, Gargollo P, Gunn S, Macias CG, McCullough LB, Roth DR, Sutton VR, Karaviti LP (2015) Androgen insensitivity syndrome: management considerations from infancy to adulthood. Pediatr Endocrinol Rev 12:373–387PubMed

106.

Palmert MR, Dunkel L (2012) Clinical practice. Delayed puberty. N Engl J Med 366:443–453PubMedCrossRef

107.

Lee PA, Houk CP, Ahmed SF, Hughes IA (2006) International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. In: Consensus statement on management of intersex disorders. International consensus conference on intersex. pediatrics, vol 118, pp e488–e500

108.

Meyer-Bahlburg HF (2011) Brain development and cognitive, psychosocial, and psychiatric functioning in classical 21-hydroxylase deficiency. Endocr Dev 20:88–95PubMed

109.

Meyer-Bahlburg HF, Zolezal C, Baker SW, New MI (2008) Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess. Arch Sex Behav 37:85–99PubMedCrossRef

110.

Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010) Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95:4133–4160PubMedPubMedCentralCrossRef

111.

Meyer-Bahlburg HF, Dolezal C, Baker SW, Ehrhardt AA, New MI (2006) Gender development in women with congenital adrenal hyperplasia as a function of disorder severity. Arch Sex Behav 35:667–684PubMedCrossRef

112.

Berembaum SA, Resnick SM (1997) Early androgen effects on aggression in children and adults with congenital adrenal hyperplasia. Psychoneuroendocrinology 22:505–515CrossRef

113.

Berenbaum SA, Hines M (1992) Early androgen are related to childhood sex-typed toy preferences. Psychol Sci 3:203–206CrossRef

114.

Berenbaum SA, Snyder E (1995) Early hormonal influences on childhood sex-typed activity and playmate development of sexual orientation. Dev Psychol 31:130–136CrossRef

115.

Dittmann RW, Kappes MH, Kappes ME, Borger D, Meyer-Bahlburg HF, Stegner H, Willig RH, Wallis H (1990) Congenital adrenal hyperplasia. I: gender-related behavior and attitudes in female patients and sisters. Psychoneuroendocrinology 15:421–434PubMedCrossRef

116.

Slijper FM (1984) Androgens and gender role behavior in girls with congenital adrenal hyperplasia (CAH). Progr Brain Res 61:417–422CrossRef

117.

Ehrardt AA, Meywe-Bahlburg HF (1981) Effects of prenatal sex hormones on gender-related behavior. Science 211:1312–1318CrossRef

118.

Leveroni CL, Berenbaum SA (1998) Early androgens effects on interest in infants: evidence from children with congenital adrenal hyperplasia. Dev Neuropsychol 14:321–324CrossRef

119.

Zucker KJ, Bradely SJ, Olived G, Blake J, Fleming S, Hood J (1996) Psychosexual development of women with congenital adrenal hyperplasia. Horm Behav 30:300–318PubMedCrossRef

120.

Pasterski VL, Zucker KJ, Hindmarsh PC, Hughes IA, Acerini CL, Spencer D, Neufeld S, Hines M (2015) Increased cross-gender identification independent of gender role behavior in girls with congenital adrenal hyperplasia: results from a standardized assessment of 4- to 11-year-old children. Arch Sex Behav 44:1363–1375PubMedCrossRef

121.

Dittman RW, Kappes ME, Kappes MH (1992) Sexual behavior in adolescent and adult females with congenital adrenal hyperplasia. Pychoneurondocrinology 17:153–170CrossRef

122.

Hines M, Brook C, Conway GS (2004) Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). J Sex Res 41:75–81PubMedCrossRef

123.

Kuhnle U, Bullinger M (1997) Outcome of congenital adrenal hyperplasia. Pediatr Surg Int 12:511–515PubMedCrossRef

124.

May B, Boyle M, Grant D (1996) A comparative study of sexual experiences: women with diabetes and women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Health Psychol 1:479–492PubMedCrossRef

125.

Meyer-Bahlburg HF (1999) What causes low rates of child-bearing in congenital adrenal hyperplasia? J Clin Endocrinol Metabol 84:1844–1847CrossRef

126.

Mulaikal RM, Migeon CJ, Rock JA (1987) Fertility rates in female patients with CAH due to 21-hydroxyase deficiency. N Eng J Med 316:178–182CrossRef

127.

Van der Zwag YG, Janssen EH, Callens N, Wolffenbuttel KP, Cohen-Kettenis PT, van de Berg M, Drop SL, Dessens AB, Beerendonk C, Dutch Study Group on DSD (2013) Severity of virilization is associated with cosmetic appearance and sexual function in women with congenital adrenal hyperplasia: a cross-sectional study. J Sex Med 10:866–875CrossRef

128.

Frisen L, Nordenstrom A, Falhammar H, Filipsson H, Holmdahl G, Janson PO, Thorén M, Hagenfeldt K, Möller A, Nordenskjöld A (2009) Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency. J Clin Endocrinol Metabol 94:3432–3439CrossRef

129.

Dessens AN, Slijper FM, Drop SL (2005) Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav 34:389–397PubMedCrossRef

130.

Gupta DK, Shilpa S, Amini AC, Gupta M, Aggarwal G, Deepika G, Jamlesh K (2006) Congenital adrenal hyperplasia: long-term evaluation of feminizing genitoplasty and psychosocial aspects. Pediatr Surg Int 22:905–909PubMedCrossRef

131.

Meyer-Bahlburg HF, Gruen RS, New MI, Bell JJ, Morishima A, Shimshi M, Bueno Y, Vargas I, Baker SW (1996) Gender change from female to male in classical congenital adrenal hyperplasia. Horm Behav 30:319–332PubMedCrossRef

132.

Jorge JC, Echeverri C, Medina Y, Acevedo P (2008) Male gender identity in an XX individual with congenital adrenal hyperplasia. J Sex Med 5:122–131PubMedCrossRef

133.

Arlt W, Krone N (2007) Adult consequences of congenital adrenal hyperplasia. Horm Res 68:158–164PubMedCrossRef

134.

Berenbaum SA, Bailey JM (2003) Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metabol 88:1102–1106CrossRef

135.

Meyer-Balhlburg HF (2009) Male gender identity in a XX individuals with congenital adrenal hyperplasia. J Sex Med 6:297–298CrossRef

136.

Sharma S, Gupta DK (2008) Gender assignment and hormonal treatment for disorders at sexual differentiation. Pediatr Surg Int 24:1131–1135PubMedCrossRef

137.

Gupta D, Bharadwaj M, Sharma S, Ammini AC, Gupta DK (2010) Long-term psychosocial adjustment, satisfaction related to gender and the family equations in disorder of sexual differentiation with male sex assignment. Pediatr Surg Int 26:955–958PubMedCrossRef

138.

Strandqvist A, Falhammar H, Lichtenstein P, Hirschberg AL, Wedell A, Norrby C, Nordenskjorl A, Frisen L, Nordenstrom A (2014) Suboptimal psychosocial outcomes in patients with congenital adrenal hyperplasia; epidemiological studies in nonbiased national cohort in Sweden. J Clin Endocrinol Metab 99:1425–1432PubMedCrossRef

139.

Reisch N, Hahner S, Bleicken B, Flade L, Pedrosa Gil F et al (2011) Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21-hydroxylase deficiency than in patient with primary adrenal insufficiency. Clin endocrinol (Oxf) 74:166–173CrossRef

140.

Palmer BW, Wisniewski AB, Schaeffer TL, Mallappa A, Tryggestad JB, Krishnan S, Chalmers LJ, Copeland K, Chernausek SD, Reiner WG, Kropp BP (2012) A model of delivering multi-disciplinary care to people with 46, XY DSD. J Pediatr Urol 8:7–16PubMedCrossRef

141.

McCarty BM, Migeon CJ, Meyer-Bahlburg HF, Zacur H, Wisniewski AB (2006) Medical and psychosexual outcome in women affected by complete gonadal dysgenesis. J Pediatr Endocrinol Metabol 19:873–877CrossRef

142.

Cornet D, Alvarez S, Antoine JM, Tibi C, Mandelbaum J, Plachot M, Salat-Baroux J (1990) Pregnancy following ovum donation in gonadal dysgenesis. Hum Reprod 5:291–293PubMed

143.

Michala L, Goswami D, Creighton SM, Conway GS (2008) Swyer syndrome: presentation and outcomes. BJOG 115:737–741PubMedCrossRef

144.

Kan AJ, Abdalla JI, Oscarsson T (1997) Two successful pregnancies in 46, XY patient. Hum Reprod 12:1434–1435PubMedCrossRef

145.

Plante BJ, Fritz MA (2008) A case report of successful pregnancy in a patient with pure 46, XY gonadal dysgenesis. Fertil Steril 90:2015.e1–2015.e2CrossRef

146.

Selvaraj K, Ganesh V, Selvaraj P (2002) Successful pregnancy in a patient with a 46, XY karyotype. Fertil Steril 78:419–420PubMedCrossRef

147.

Cools M, Looijenga LH, Wollfenbuttel KP, Drop SL (2009) Disorders of sex development: update on the genetic background, terminology and risk for the development of germ cell tumors. Worl J Pediatr 5:93–102CrossRef

148.

Migeon CJ, Krishnan S, Wisniewski AB (2007) Ambiguous genitalia in the newborn. In: Pediatric endocrinology, 1st edn, Chap. 16. http://www.endotext.org/pediatrics/pediatrics10/pediatricsframe10.htm

149.

Mazur T (2005) Gender dysphoria and gender changes in androgen insensitivity or micropenis. Arch Sex Behav 34:411–421PubMedCrossRef

150.

Hughes IA, Davies JD, Bunch TI, Pasterski V, Mastroyannopoulou K, MacDougall J (2012) Androgen insensitivity syndrome. Lancet 380:1419–1428PubMedCrossRef

151.

Liu AX, Shi HY, Cai ZJ, Liu A, Zhang D, Huang HF, Jin HM (2014) Increased risk of gonadal malignancy and prophylactic gonadectomy: a study of 102 phenotypic female patients with Y chromosome or Y-derived sequences. Hum Reprod 29:1413–1419PubMedCrossRef

152.

Nakhal RS, Hall-Craggs M, Freeman A, Kirkham A, Conway GS, Arora R, Woodhouse CR, Wood DN, Creighton SM (2013) Evaluation of retained testes in adolescent girls and women with complete androgen insensitivity syndrome. Radiology 268:153–160PubMedCrossRef

153.

Masica DN, Money J, Ehrhardt AA (1971) Fetal feminization and female gender identity in the testicular feminizing syndrome of androgen insensitivity. Arch Sex Behav 1:131–142PubMedCrossRef

154.

Hines M, Ahmed SF, Hughes IA (2003) Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav 32:93–101PubMedCrossRef

155.

Melo KF, Menodanca BB, Billerbeck AE, Costa EM, Inacio M, Silva FA, Leal AM, Latronico AC, Arnhold IJ (2003) Clinical, hormonal, behavioral and genetic characteristics of androgen insensitivity syndrome in a Brazilian cohort: five novel mutations in the androgen receptor gene. J Clin Endocrinol Metab 88:3241–3250PubMedCrossRef

156.

Jürgensen M, Hiort O, Holterhus PM, Thyen U (2007) Gender role behavior in children with XY karyotype and disorders of sex development. Horm Behav 51:443–453PubMedCrossRef

157.

Kulshreshtha B, Philibert P, Eunice M, Khandelwal SK, Mehta M, Audran F, Paris F, Sultan C, Ammini AC (2009) Apparent male gender identity in a patient with complete androgen insensitivity syndrome. Arch Sex Behav 38:873–875PubMedCrossRef

158.

T’Sjoen G, De Cuypere G, Monstray S, Hoebeke P, Freedman FK, Appari M, Holterhus PM, Van Borsel J, Cools M (2011) Male gender identity in complete androgen insensitivity syndrome. Arch Sex Behav 40:635–638PubMedCrossRef

159.

Herdt GH, Davidson J (1988) The Sambia “turnim-man”: sociocultural and clinical aspects of gender formation in male pseudohermaphrodites with 5-alpha-reductase deficiency in Papua New Guinea. Arch Sex Behav 17:33–56PubMedCrossRef

160.

Ademola Akesode F, Meyer WJ, Migeon CJ (1977) Male pseudohermaphroditism with gynecomastia due to testicular 17-ketosteroid reductase deficiency. Clin Endocrinol (Oxf) 7:443–452CrossRef

161.

Bertelloni S, Dati E, Hiort O (2009) Diagnosis of 17beta-hydroxysteoid dehydrogenase deficiency. Expert Rev Endocrinol Metab 4:53–65CrossRef

162.

Hiort O, Renecke S, Thyen U, Jürgensen M, Holterhus PM, Schön D, Richter-Appelt H (2003) Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 16:297–306PubMed

163.

Boehemer AL, Brinkmann AO, Sandjuij LA, Halleym DJ, Niermeijer MF, Andersson S, de Jong FH, Kayserili H, de Vroede MA, Otten BJ, Rouwé CW, Mendonça BB, Rodrigues C, Bode HH, de Ruiter PE, Delemarre-van de Waal HA, Drop SL (1999) 17beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics and word wide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 84:4713–4721

164.

Galdiero M, Vitale P, Simeoli C, Afeltra L, Melis D, Alviggi C, Cariati F, Lo Calzo F, Di Somma C, Colao A, Pivonello R (2013) The 17β-hydroxysteroid dehydrogenase type 3 deficiency: a case report of an 18-year patient and review of the literature. Minerva Endocrinol 38:113–122PubMed

165.

Jürgensen M, Hampel E, Hiort O, Thyen U (2006) “Any decision is better than none” decision-making about sex of rearing for siblings with 17beta-hydroxysteroid-dehydrogenase-3 deficiency. Arch Sex Behav 35:359–571PubMedCrossRef

166.

Mendonca BB, Inacio M, Arnhold IJ, Costa EM, Bloise W, Martin RM, Denes FT, Silva FA, Andersson S, Lindqvist A, Wilson JD (2000) Male pseudohermaphroditism due to 17beta-hydroxysteroid dehydrogenase-3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 79:299–309CrossRef

167.

Rosler A (1992) Steroid 17beta-hydroxysteroid dehydrogenase-3 deficiency in man: an inherited form of male pseudohermaphroditism. J Steroid Biochem Mol Biol 43:989–1002PubMedCrossRef

168.

Chuang J, Vallerie A, Breech L, Saal HM, Alam S, Crawford P, Rutter MM (2013) Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy? Int J Pediatr Endocrinol 2013:15PubMedPubMedCentralCrossRef

169.

Deeb A, Mason C, Lee YS, Hughes IA (2005) Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin Endocrinol (Oxf) 63:56–62CrossRef

170.

Joseph AA, Shabir I, Marumadi E, Dada R, Ammini AC, Mehta M (2013) Psychosexual outcomes in three siblings with partial androgen insensitivity syndrome: impact of nature versus nurture. J Pediatr Endocrinol Metabol 26:915–920CrossRef

171.

Money J, Onguro C (1974) Behavioral sexology: ten cases of genetic male intersexuality with impaired prenatal and pubertal androgenization. Arch Sex Behav 3:181–205PubMedCrossRef

172.

Lee PA, Houk CP (2004) Outcome studies among men with micropenis. J Pediatr Endocrinol Metab 17:1043–1053PubMed

173.

Callens N, Hoebeke P (2014) Phalloplasty: a panacea for 46, XY disorders of sex development conditions with penile deficiency? Endocr Dev 24:222–233

174.

Callens N, De Cuypere G, T’Sjoen G, Monstrey S, Lumen N, Van Laecke E, Hoebeke P, Cools M (2014) Sexual quality of life after total phalloplasty in men with penile deficiency: an exploratory study. World J Urol 33:137–143PubMedCrossRef

175.

Callens N, De Cuypere G, Van Hoecke E, T’Sjoen G, Monstrey S, Cools M, Hoebeke P (2013) Sexual quality of life after hormonal and surgical treatment, including phalloplasty in men with micropenis: a review. J Sex Med 10:3006–3018PubMedCrossRef

176.

Reilly JM, Woodhouse CR (1989) Small penis and male sexual role. J Urol 142:569–571PubMedCrossRef

177.

Diamond M, Sigmudson HK (1997) Management of intersexuality. Guidelines for dealing with persons with ambiguous genitalia. Arch Pediatr Adolesc Med 151:1046–1105PubMedCrossRef

178.

Reiner WG (1997) Sex assignment in the neonate with intersex or inadequate genitalia. Arch Pediatr Adolesc Med 151:1044–1045PubMedCrossRef

179.

Meyer-Bahlburg HF (2005) Gender identity outcome in female raised 46 XY persons with penile agenesis, cloacal exstrophy of the bladder or penile ablation. Arch Sex Behav 34:423–438PubMedCrossRef

180.

Reiner WG, Gearhart JP (2004) Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth. N Eng J Med 350:333–341CrossRef

181.

Diamond DA, Burns JP, Huang L, Rosoklija I, Retik AB (2011) Gender assignment for newborns with 46XY cloacal exstrophy: a 6-year followup survey of pediatric urologists. J Urol 186:1642–1648PubMedCrossRef

182.

Schonbucher VB, Landolft MA, Gobert R, Weber DM (2008) Psychosexual development of children and adolescents with hypospadias. J Sex Med 5:1365–1373PubMedCrossRef

183.

Sandberg DE, Meyer-Bahlburg HF, Yager TJ, Hensle TW, Levitt SB, Kogan SJ, Reda EF (1995) Gender development in boys born with hypospadias. Psychoneuroendocrinology 20:693–709PubMedCrossRef

184.

Inoubli A, De Cuypere G, Rubens R, Heylens G, Elaut E, Van Caenegem E, Menten B, T’Sjoen G (2011) Karyotyping, is it worthwhile in transsexualism? J Sex Med 8:475–478PubMedCrossRef

185.

Maeda T, Ohno M, Matsunobu A, Yoshihara K, Yabe N (1991) A cytogenetic survey of 14,835 consecutive liveborns. Jinrui Idengaku Zasshi 36:117–129PubMedCrossRef

186.

Fisher AD, Castellini G, Casale H, Fanni E, Bandini E, Campone B, Ferruccio N, Maseroli E, Boddi V, Dèttore D, Pizzocaro A, Balercia G, Oppo A, Ricca V, Maggi M (2015) Hypersexuality, paraphilic behaviors, and gender dysphoria in individuals with Klinefelter’s syndrome. J Sex Med 12:2413–2424PubMedCrossRef

187.

Hughes IA, Deeb A (2006) Androgen resistance. Best Pract Res Clin Endocrinol Metab 20:577–598PubMedCrossRef

188.

Kolesinska Z, Ahmed SF, Niedziela M, Bryce J, Molinska-Glura M, Rodie M, Jiang J, Sinnott RO, Hughes IA, Darendeliler F, Hiort O, van der Zwan Y, Cools M, Guran T, Holterhus PM, Bertelloni S, Lisa L, Arlt W, Krone N, Ellaithi M, Balsamo A, Mazen I, Nordenstrom A, Lachlan K, Alkhawari M, Chatelain P, Weintrob N (2014) Changes over time in sex assignment for disorders of sex development. Pediatrics 134:e710–e715PubMedCrossRef

189.

Cox K, Bryce J, Jiang J, Rodie M, Sinnott R, Alkhawari M, Arlt W, Audi L, Balsamo A, Bertelloni S, Cools M, Darendeliler F, Drop S, Ellaithi M, Guran T, Hiort O, Holterhus PM, Hughes I, Krone N, Lisa L, Morel Y, Soder O, Wieacker P, Ahmed SF (2014) Novel associations in disorders of sex development: findings from the I-DSD registry. J Clin Endocrinol Metab 99:348–355CrossRef

190.

Hiort O, Wünsch L, Cools M, Looijenga L, Cuckow P (2012) Requirements for a multicentric multidisciplinary registry on patients with disorders of sex development. J Pediatr Urol 8:624–628PubMedCrossRef

Titel: Gender identity, gender assignment and reassignment in individuals with disorders of sex development: a major of dilemma
verfasst von: A. D. Fisher
J. Ristori
E. Fanni
G. Castellini
G. Forti
M. Maggi
Publikationsdatum: 01.11.2016
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 11/2016
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-016-0482-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Aims

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2016

Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome

Positive correlation of serum HDL cholesterol with blood mercury concentration in metabolic syndrome Korean men (analysis of KNANES 2008–2010, 2013)

Controversies in the management of Graves’ disease in children

Judith and her Maidservant: a goitrous heroin in two masterpieces

In remembrance of Professor Loredana Gandini (1957–2016)